• Resistant Hypertension

  Reaven GM, Lithell H, Landsberg L (1996) Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system. [link.springer.com]

  Neurogenic hypertension is most likely to occur in patients with labile or paroxysmal hypertension, but evidence of increased sympathetic tone also suggests a neurogenic component in hypertension in patients with severe or resistant hypertension, chronic [pubmed.ncbi.nlm.nih.gov]

• Inflammation

  Wenzel UO, Bode M, Kurts C, Ehmke H (2018) Salt, inflammation, IL-17 and hypertension. Br J Pharmacol. https://doi.org/10.1111/bph.14359 Article PubMed Google Scholar 36. [link.springer.com]

• Anger

  Suls J, Wan CK, Costa Jr PT (1995) Relationship of trait anger to resting blood pressure: a meta-analysis. Heal Psychol 14:444–456. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed3&AN=7498116 12. [link.springer.com]

• Suggestibility

  In this review I discuss the pathophysiology of neurogenic hypertension, the controversy of renal versus central origin, the clinical clues that suggest neurogenic hypertension, and the interventions best suited in its treatment. [pubmed.ncbi.nlm.nih.gov]

• Hyperactivity

  Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ (2004) Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. [link.springer.com]

Fadl Elmula FEM, Hoffmann P, Larstorp AC et al (2014) Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. [link.springer.com]

The importance of combined alpha- and beta-blockade in pharmacologic treatment and the status of renal denervation are discussed. [pubmed.ncbi.nlm.nih.gov]

Jannetta PJ, Segal R, Wolfson SK (1985) Neurogenic hypertension: etiology and surgical treatment. I. Observations in 53 patients. Ann Surg 201(3):391–398. http://www.ncbi.nlm.nih.gov/pubmed/3977442 47. [link.springer.com]

Affiliations PMID: 29974290 DOI: 10.1007/s10286-018-0541-z Review Neurogenic hypertension: pathophysiology, diagnosis and management Samuel J Mann. Clin Auton Res. 2018 Aug. [pubmed.ncbi.nlm.nih.gov]

In: Laragh JH, Brenner BM (ed) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven Press, New York, pp 399–407 18. Ball SG (1989) The sympathetic nervous system and converting enzyme inhibition. [link.springer.com]

ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). [link.springer.com]